![](/img/cover-not-exists.png)
The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA
Lyu, M.-A., Cheung, L. H., Hittelman, W. N., Marks, J. W., Aguiar, R. C.T., Rosenblum, M. G.Volume:
6
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.mct-06-0254
Date:
February, 2007
File:
PDF, 693 KB
english, 2007